Evaluation of hemastasis effect by chitosan gauze in obstetrics and gynecology field

Evaluation of hemastasis effect by chitosan gauze in obstetrics and gynecology field - Clinical trial of chitosan gauze in obstetrics and gynecology field

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054122

Enrollment

Registered

2024-04-15

Start date

2024-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

birth canal injury

Interventions

Chitosan gauze is used for hemostasis in birth canal injury that is difficult to stop bleeding by surgical suture. The gauze is removed after 30 minutes to evaluate the hemostasis effect.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Expectant mothers who are plannning to labour in our hospital from April 2024, obtained written informed consent.

Exclusion criteria

Exclusion criteria: minor

Design outcomes

Primary

Measure	Time frame
hemostasis effect after 30-minute vaginal use of chitosan gauze	—

Secondary

Measure	Time frame
hemorrhage from vaginal injury use of blood transfusion presence of postpartum anemia presence of inflammation after gauze use	—

Countries

Japan

Contacts

Public ContactKiguna Sei

Seirei Hamamatsu General Hospital Department of Obstetrics and Gynecology

k.sei@sis.seirei.or.jp0534742222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026